Recognizing and Effectively Treating Gastroparesis

被引:0
作者
Terrie, Yvette C.
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gastroparesis (GP) is a chronic neuromuscular disorder of the upper gastrointestinal tract that is characterized by a delay in gastric emptying that lessens the ability of the stomach to empty in the absence of an obstruction. GP can significantly impact a patient's quality of life. Although the exact cause of GP is unknown, the three primary classifications are diabetic, postsurgical, and idiopathic. GP may be exacerbated by the use of certain pharmacologic agents, such as opioids. Pharmacists are in a pivotal position to identify agents that may delay gastric emptying in this patient population. To date, treatment options are limited but may include dietary modification, medications to accelerate gastric emptying, antiemetic agents, gastric electrical stimulation, and surgery.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 30 条
  • [1] American College of Gastroenterology, GASTR
  • [2] American Diabetes Association, GASTR
  • [3] [Anonymous], 2017, VASCEPA PACK INS
  • [4] Bhatt D.L., 2018, N ENGL J MED
  • [5] Novel Diet, Drugs, and Gastric Interventions for Gastroparesis
    Camilleri, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (08) : 1072 - 1080
  • [6] Clinical Guideline: Management of Gastroparesis
    Camilleri, Michael
    Parkman, Henry P.
    Shafi, Mehnaz A.
    Abell, Thomas L.
    Gerson, Lauren
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01) : 18 - 37
  • [7] Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis
    Camilleri, Michael
    Bharucha, Adil E.
    Farrugia, Gianrico
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 5 - 12
  • [8] Nausea and vomiting in diabetic and idiopathic gastroparesis
    Cherian, D.
    Parkman, H. P.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (03) : 217 - E103
  • [9] DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI [10.1185/03007990802418851, 10.1185/03007990802418851 ]
  • [10] Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction
    Delgado-Aros, S
    Vella, A
    Camilleri, M
    Low, PA
    Burton, DD
    Thomforde, GM
    Stephens, D
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2003, 15 (04) : 435 - 443